Screener
Cardiol Therapeutics CRDL Q4 2025 earnings
Reported March 30, 2026 · Before market open
EPS-$0.05Beat by $0.04
EPS estimate-$0.09
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did Cardiol Therapeutics report Q4 2025 earnings?
- Cardiol Therapeutics (CRDL) reported Q4 2025 earnings on March 30, 2026 before market open.
- What were Cardiol Therapeutics's Q4 2025 revenue and EPS?
- Cardiol Therapeutics reported eps of $-0.05 for Q4 2025.
- Did Cardiol Therapeutics beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.09 by $0.04.
- How did Cardiol Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 27.2% from $-0.07.
